Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,717 | 138 | 93.3% |
| Education | $195.39 | 3 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $573.96 | 25 | $0 (2024) |
| Boston Scientific Corporation | $340.69 | 10 | $0 (2023) |
| PFIZER INC. | $243.14 | 17 | $0 (2024) |
| Coloplast Corp | $150.70 | 9 | $0 (2022) |
| Seattle Genetics, Inc. | $135.37 | 3 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $134.54 | 7 | $0 (2020) |
| Janssen Biotech, Inc. | $130.24 | 7 | $0 (2024) |
| Teleflex LLC | $123.01 | 4 | $0 (2024) |
| Myovant Sciences Inc. | $122.36 | 8 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $82.54 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.57 | 9 | Astellas Pharma US Inc ($94.36) |
| 2023 | $270.89 | 13 | Janssen Biotech, Inc. ($59.24) |
| 2022 | $413.99 | 20 | Astellas Pharma US Inc ($136.95) |
| 2021 | $83.65 | 4 | PFIZER INC. ($25.33) |
| 2020 | $276.01 | 17 | PFIZER INC. ($50.72) |
| 2019 | $702.62 | 32 | Astellas Pharma US Inc ($220.52) |
| 2018 | $509.62 | 25 | BOSTON SCIENTIFIC CORPORATION ($93.26) |
| 2017 | $413.46 | 21 | BOSTON SCIENTIFIC CORPORATION ($113.15) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Oncology | ||||||
| 05/03/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 03/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINES | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 02/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $63.75 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 01/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Urology | ||||||
| 10/25/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: VACCINES | ||||||
| 09/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Oncology | ||||||
| 08/03/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: rezum_URO | ||||||
| 06/28/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 06/07/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: HORMONE THERAPY | ||||||
| 06/05/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Oncology | ||||||
| 05/24/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 04/04/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diagnostics | ||||||
| 03/15/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Oncology | ||||||
| 01/24/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Diabetes | ||||||
| 01/17/2023 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: rezum_URO | ||||||
| 12/07/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: HORMONE THERAPY | ||||||
| 10/31/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Urology | ||||||
| 10/19/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 524 | 685 | $117,462 | $49,273 |
| 2022 | 8 | 391 | 499 | $75,194 | $31,080 |
| 2021 | 6 | 257 | 314 | $40,241 | $17,903 |
| 2020 | 7 | 267 | 332 | $55,859 | $14,681 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 248 | $39,839 | $16,758 | 42.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 50 | 61 | $26,413 | $11,400 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 95 | $21,563 | $9,024 | 41.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $15,800 | $6,420 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $8,880 | $3,552 | 40.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 23 | 23 | $3,404 | $1,480 | 43.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 96 | 123 | $1,070 | $419.43 | 39.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 25 | 26 | $493.60 | $219.12 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 181 | $28,890 | $12,087 | 41.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 29 | 34 | $14,912 | $6,662 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 82 | 82 | $16,186 | $5,587 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 23 | $5,175 | $2,334 | 45.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 43 | 50 | $4,980 | $2,122 | 42.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 22 | 22 | $3,841 | $1,809 | 47.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 63 | 79 | $687.30 | $272.10 | 39.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 26 | 28 | $522.00 | $206.23 | 39.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 74 | 74 | $14,578 | $6,378 | 43.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 73 | $11,753 | $5,422 | 46.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 18 | 20 | $8,680 | $3,972 | 45.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,848 | $1,559 | 40.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 81 | 113 | $983.10 | $393.24 | 40.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 20 | 21 | $399.00 | $178.60 | 44.8% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 36 | 37 | $17,612 | $5,396 | 30.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 122 | $20,984 | $4,887 | 23.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 61 | 72 | $7,344 | $1,793 | 24.4% |
About Ahmed Haddad
Ahmed Haddad is a Urology healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2014. The National Provider Identifier (NPI) number assigned to this provider is 1700297728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ahmed Haddad has received a total of $2,913 in payments from pharmaceutical and medical device companies, with $242.57 received in 2024. These payments were reported across 141 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,717).
As a Medicare-enrolled provider, Haddad has provided services to 1,439 Medicare beneficiaries, totaling 1,830 services with total Medicare billing of $112,937. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Riverside, CA
- Active Since 05/13/2014
- Last Updated 04/14/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1700297728
Products in Payments
- XTANDI (Drug) $272.74
- Xtandi (Drug) $182.77
- ORGOVYX (Drug) $139.17
- XIAFLEX (Biological) $134.54
- UROLIFT (Device) $123.01
- ERLEADA (Drug) $104.07
- ARTIFICIAL URINARY SPHINCTER (Device) $101.43
- MYRBETRIQ (Drug) $99.01
- AMS (Device) $93.38
- KEYTRUDA (Biological) $82.54
- SUTENT (Drug) $76.55
- CONTINENCE CARE (Device) $67.26
- Axumin (Drug) $65.33
- SPEEDICATH (Device) $64.28
- GEMTESA (Drug) $63.15
- FOUNDATIONONE (Device) $50.22
- Rezum Generator (Device) $49.87
- VESICARE (Drug) $48.55
- LoFric (Device) $42.69
- VOTRIENT (Drug) $41.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Riverside
Dr. Ken Takesita, M.d, M.D
Urology — Payments: $17,166
Howard Aubert, Md, MD
Urology — Payments: $13,036
Benjamin Yang, M.d, M.D
Urology — Payments: $7,030
Brandon Louie, M.d, M.D
Urology — Payments: $2,143
Anthony Park, Md, MD
Urology — Payments: $1,776
Paul Gweon, Md, MD
Urology — Payments: $1,549